BioMarin Pharmaceutical Inc. (LON: 0HNC)

BioMarin Pharmaceutical Revenue

BioMarin Pharmaceutical had revenue of $745.74M USD in the quarter ending September 30, 2024, with 28.28% growth. This brings the company's revenue in the last twelve months to $2.75B, up 19.14% year-over-year. In the year 2023, BioMarin Pharmaceutical had annual revenue of $2.42B with 15.42% growth.

• Revenue (ttm): $2.75B
• Revenue Growth: +19.14%
• P/S Ratio: n/a
• Revenue / Employee: $809.41K
• Employees: 3,401
• Market Cap: 9.60B GBP

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	2.42B	323.19M	15.42%
Dec 31, 2022	2.10B	249.76M	13.53%
Dec 31, 2021	1.85B	-14.18M	-0.76%
Dec 31, 2020	1.86B	156.41M	9.18%
Dec 31, 2019	1.70B	212.84M	14.27%